Vaccine News Daily | iBio, Inc., receives patents for influenza antibodies Vaccine News Daily iBio, Inc., said on Thursday that it received two U.S. patents for monoclonal antibodies that target influenza by blocking critical functions of the virus necessary for infection or replication. “Current public health strategies for influenza include ... |
